常州市第一人民医院，是中华人民共和国江苏省的一所医院，为三级甲等医院，位于常州市局前街185号。它始创于1918年。

During the past decade, The First People's Hospital of Changzhou conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 8 clinical trials were completed, i.e. on average, 11.6% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 4 clinical trials were completed. i.e. 10.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First People's Hospital of Changzhou" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Takeda" with 5 trials sponsored, "Nanjing First Hospital, Nanjing Medical University" with 4 trials sponsored and "Wujin People's Hospital" with 4 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First People's Hospital of Changzhou" #1 collaborator was "Affiliated Hospital of Nantong University" with 2 trials as a collaborator, "The First People's Hospital of Changzhou" with 2 trials as a collaborator, "Baotou Central Hospital" with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator and "Beijing Hospital" with 1 trials as a collaborator. Other collaborators include 72 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "The First People's Hospital of Changzhou" are "Gastric Cancer" (7 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Crohn's Disease" (4 trials), "Distal Radial Artery" (3 trials) and "Ischemic Stroke" (3 trials). Many other conditions were trialed in "The First People's Hospital of Changzhou" in a lesser frequency.

Most popular intervention types in "The First People's Hospital of Changzhou" are "Drug" (56 trials), "Device" (9 trials), "Procedure" (9 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Lansoprazole" (5 trials), "Lansoprazole Placebo" (5 trials), "Atezolizumab" (4 trials) and "Capecitabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "The First People's Hospital of Changzhou" are 80 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The First People's Hospital of Changzhou". 8 are not yet recruiting, 26 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in The First People's Hospital of Changzhou, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The First People's Hospital of Changzhou, 3 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 16 trials that are defined as “Not Applicable".